Rabia Nagda, MD, of Texas Children’s Pediatrics, emphasizes that every environment where kids spend time should be built with fall risk in mind.
Confluence Health’s transitional care program enlists semi-retired and retired doctors to cut wait times, improve follow-up care and support care teams.
Find out how to participate in the CPT process by attending an Editorial Panel meeting or applying for a new or updated CPT code.
VeriCre™ helps overcome one of the most consequential challenges in the credentialing process—receiving verified data in applications quickly and reliably
The AMA backs bipartisan legislation to reissue 40,000 unused immigrant visas for physicians and nurses.
Giving feedback that harnesses surgical residents’ thirst for improvement is a winner at Geisinger. The approach is spreading to other specialties.
Find information about the responsibilities and terms of service for the Government Relations Advocacy Fellow (GRAF) and how to apply.
Medical students at Geisinger Commonwealth School of Medicine have a special chance to ease debt burdens and meet rural health needs. Find out how.
In residency and fellowship training, the business side of medicine often gets short shrift. Catch up on what you need to succeed in health care.
ACGME-required midyear reviews shouldn’t be taken for granted. The feedback might sting, but this is your chance to drill down for specifics.
Stay up to date on OBBBA implementation and related federal rulemaking with resources from the AMA.
Supporting the Improving Seniors’ Timely Access to Care Act, details on the FDA TEMPO model and more in the latest National Advocacy Update.
ChangeMedEd® is a national bi-annual conference that brings together innovative leaders across the medical education continuum to reimagine the way future physicians are trained. Learn more.
This two-day boot camp, April 13-14, 2026, will equip attendees with the time-saving tools and strategies to reform their organizations and enhance professional satisfaction.
Find out about the election bylaws and policies for being elected to the AMA House of Delegates.
Find out about opportunities for representation of Federation organizations in the AMA sections' annual and interim meetings.
Download PDFs of reports from the Council on Medical Education presented during the AMA Annual and Interim Meetings.
Download PDFs of reports on this topic from the Council on Medical Education presented during the AMA Interim and Annual Meetings.
Recap of the joint CME education event at I-25 and a review of the strategic goals for 2025-26.
Read current and past issues of WPS Members & News Highlights for the latest information on the work being done by WPS members and its leadership.
In the news: Changes to federal vaccine recommendations, GLP-1s and obesity-related cancer risk, uterine fibroids may raise heart disease risk and more.
Review a list of USAN Council-approved stems and which chemical and/or pharmacologic parameters have been established.
Substance misuse affects millions of Americans every year. The AMA is committed to addressing the root causes of substance misuse in America.
Advocacy spotlights new cyber treats during COVID-19 and physician protections as well as new policies for opioid treatment programs.
The Maine Executive Order is the type of state action the AMA is encouraging as part of harm reduction policy efforts.
The DEA is allowing qualified physicians to prescribe buprenorphine over the telephone so patients can stay home. The AMA urges states to do the same.
During COVID-19, the number of patients requiring ventilators has resulted in huge spikes in demand for controlled substances.
Minnesota chronic pain patients will have increased access to the medications they need thanks to a new state law.
This guidance removes a considerable barrier for many patients during the COVID-19 national emergency and, importantly, allows them to stay at home.
The AMA provides guidance on caring for patients with substance use disorder, mental illness or chronic pain during the COVID-19 pandemic.
The joint statement is in response to reports of physicians and others prophylactically prescribing, medications currently identified as potential treatments for COVID-19.
The blanket exception will allow patients to obtain up to 28 days of take-home medication if they are stable and up to 14 days for patients who are less stable.
